Therefore, we suggested here that AT2 receptor activation reduces RAGE expression possibly by attenuating oxidative stress and MCP-1/IL-1β-mediated inflammation in the cerebrovasculature and thus contributing to inhibition of cognitive decline. The gene discussed is IL1B; the disease is Mental deterioration.